Genomic Valley Biotech Share Price
29.88+0.00 (+0.00%)
-26.98% past 1 Year
Genomic Valley Biotech Ltd was Incrporated in the year of 1994. It is established to do business in the area of Sales & Services. Further this company has business activity
Corporate filings & documents
Announcements
Intimation of approval of Extension of time for holding Annual General Meeting (AGM) of the company for the financial year ended on 31st March 2026 pursuant to regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.
3 days agoIntimation of approval of Extension of time for holding Annual General Meeting (AGM) of the company for the financial year ended on 31st March 2026 pursuant to regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.
3 days agoPlease find enclosed herewith unaudited financial results for the quarter ended on 30th June 2026.
2 weeks agoPlease find enclosed herewith unaudited financial results for the quarter ended on 30th June 2026.
2 weeks agoUnaudited financial results for Quarter ended on 30 June 2026.
2 weeks agoUnaudited financial results for Quarter ended on 30 June 2026.
2 weeks agoConsidered and approved the standalone Un-audited financial results of the company for the quarter ended on 30th June 2026.
2 weeks agoConsidered and approved the standalone Un-audited financial results of the company for the quarter ended on 30th June 2026.
2 weeks agoGenomic Valley Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 inter alia to consider and approve unaudited financial results (standalone) of the Company for the quarter ended on June 30 2026.
4 weeks agoGenomic Valley Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 inter alia to consider and approve unaudited financial results (standalone) of the Company for the quarter ended on June 30 2026.
4 weeks agoCertificate under Regulation 74 (5) of SEBI (DP) Regulations 2018 for the quarter ended on 30th June 2026.
1 month agoCertificate under Regulation 74 (5) of SEBI (DP) Regulations 2018 for the quarter ended on 30th June 2026.
1 month agoClosure of trading window.
2 months agoClosure of trading window.
2 months agoPlease find enclosed herewith audited financial results for the quarter and year ended on 31 March 2026.
3 months agoPlease find enclosed herewith audited financial results for the quarter and year ended on 31 March 2026.
3 months agoAppointment of Mr. Navjyoti Kumar Jha as internal auditor of the company for the F.Y. 2026-27.
3 months agoAppointment of Mr. Navjyoti Kumar Jha as internal auditor of the company for the F.Y. 2026-27.
3 months agoStandalone audited financial results of the company for the quarter and year ended on 31 March 2026.
3 months ago1. Considered and approved the standalone audited financial results of the company for the quarter and financial year ended 31st March 2026; 2. Considered and approved the appointment of Mr. Navjyoti Kumar Jha as Internal Auditor of the company for the F.Y. 2026-27.
3 months ago1. Considered and approved the standalone audited financial results of the company for the quarter and financial year ended 31st March 2026; 2. Considered and approved the appointment of Mr. Navjyoti Kumar Jha as Internal Auditor of the company for the F.Y. 2026-27.
3 months agoGenomic Valley Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 inter alia to consider and approve the audited financial results (standalone) of the Company for the quarter and year ended March 31 2026.
3 months agoCertificate under Regulation 74 (5) of SEBI (DP) Regulations 2018 for the quarter ended on 31st March 2026.
4 months agoCertificate under Regulation 74 (5) of SEBI (DP) Regulations 2018 for the quarter ended on 31st March 2026.
4 months agoDisclosure made by Promoters and Promoters group of the company under Regulation 31(4) of SEBI (substantial Acquisition of Shares and Takeovers) Regulations 2011 for the financial year ended on March 31 2026.
5 months agoDisclosure made by Promoters and Promoters group of the company under Regulation 31(4) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations 2011 for the financial year ended March 31 2026.
5 months agoClosure of Trading Window for the quarter and year ending on March 31 2026.
5 months agoClosure of Trading Window for the quarter and year ending on March 31 2026.
5 months agoPlease find enclosed herewith unaudited financial results for the quarter and nine months ended on 31st December 2025.
7 months agoCessation of Mr. Ashok Kumar (DIN: 07647876) from the directorship of the company.
7 months agoPlease find enclosed herewith the financial results for the Quarter and Nine Months ended 31st December 2025 pursuant to Regulation 33 of the SEBI (Listing Obligation and Disclosure Requirements) Regulation 2015.
7 months agoPlease find enclosed herewith the Outcome of the Board Meeting dated 15/01/2026 for your reference.
7 months agoCertificate under Regulation 74 (5) of SEBI (DP) Regulations 2018 for the quarter ended on 31st December 2025.
8 months agoGenomic Valley Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/01/2026 inter alia to consider and approve the unaudited financial results (standalone) of the Company for the quarter ended on December 31 2025.
8 months agoSubmission of voting results of 31st Annual General Meeting of the Company under Regulation 44(3) of the SEBI (listing Obligations & Disclosure Requirements) Regulations 2015.
8 months agoPlease find enclosed herewith copy of proceeding of 31st Annual General Meeting of the company for your reference.
8 months agoPlease find enclosed herewith intimation of closure of trading window.
8 months agoPlease find enclosed herewith Newspaper intimation for the 31st Annual General Meeting for your reference.
8 months agoPlease find enclosed herewith the Notice of the Annual General Meeting for your reference.
8 months agoCompliance Under Regulation 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015- Annual Report for The Financial Year 2024-25
8 months agoPlease find enclosed herewith book closure intimation for your reference.
8 months agoPlease Find enclosed herewith the Outcome of the Board Meeting dated 08/12/2025 for your reference.
8 months agoPlease find enclosed herewith un-audiited financial results for the quarter and half year ended on 30th September 2025.
10 months agoPlease find enclosed herewith unaudited standalone financial results for the Quarter and half Yearly ended on September 30th 2025.
10 months agoPlease find enclosed herewith Outcome of Board Meeting Pursuant to regulation 30 of Sebi (LODR)Regulation 2015 held on today i.e. 15th October 2025
10 months agoCertificate under Regulation 74 (5) of SEBI (DP) Regulation 2018 for the quarter ended on 30th September 2025.
10 months agoGenomic Valley Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/10/2025 inter alia to consider and approve The unaudited financial results (standalone) of the Company for the quarter and half year ended 30th September 2025.
11 months agoPlease find enclosed herewith Intimation for closure of trading window.
11 months agoIntimation of Approval of Extension of time for holding Annual General Meeting (AGM) of the Company for the Financial Year ended on 31st March 2025 pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015
12 months agoAnnual reports
Concalls & investor presentations
No presentations found
Corporate Actions
Date
Type
Details
No data available.
Company details
Registered office
4 Km Stone, Berri Chharra Road P O Tanda Heri Tehsil- Bahadurgarh Jhajjar Dist Haryana PIN: 124507 Tel No: 9811341542 Fax No: NULL Email: [email protected] Internet: www.genomicvalley.com
Registrars
Beetal House , 99 Mandangir,3rd Floor, Behind Local Shopping Centre,Near Dada Harsukhdas Mandir,New Delhi Beetal House , 99 Mandangir 3rd Floor, Behind Local Shopping Centre Near Dada Harsukhdas Mandir PIN: Tel No: 011-29961281 -82 Fax No: 011-29961284 Email: NULL
Management
Yogesh Agrawal, Managing Director & Chief Financial Officer
Parul Agrawal, Non Executive Director
Satendra Kumar Goyal, Non Executive Independent Director
Anupam Aditya, Company Secretary & Compliance Officer
Yogainder Kumar Gupta, Non Executive Independent Director
Details
BSE 539206
NSE NULL
ISIN INE574D01010